HitGen-DNA Encoded Library

DNA Encoded Library

1.2 Trillion compounds in HitGen's DNA-encoded chemical libraries, for your innovative drug discovery

DEL for: Precision alignment between DEL capabilities and industry needs. Addressing key pain points across the drug discovery pipeline.

DNA Encoded Library Design and Synthesis: Pioneering the future of drug discovery with cutting-edge DEL technology - we build world-class molecular libraries through innovative approaches. Our digital-powered DEL ecosystem connects all elements of the discovery process, accelerating breakthroughs in biopharmaceutical innovation.

DNA Encoded Library Screening: DNA Encoded Library Screening (also known as DEL selection) is an affinity selection process. DEL screening can easily accesses trillions of physically existing compounds, saving in protein/target consumption, short duration in hit identification and validation and be more cost effective.

OpenDEL ^™: OpenDEL™ is an open-access small molecule screening platform that enables fully autonomous DNA-Encoded library (DEL) exploration. With complete data transparency and open architecture, we empower researchers to validate every innovative idea, starting your journey to access the vast DEL space.

Thanks for reading!

For more details on how we can advance your innovative drug discovery projects

Sites: HitGen Inc.

Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China

Tel : +86-28-8519-7385

HitGen Pharmaceuticals Inc.(US Subsidiary)

Tel : +1-(508)-840-9646

Vernalis (R&D) Limited (UK Subsidiary)

Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom

Tel : +44(0)1223-895555

Contact: Business Inquiry : bd@hitgen.com; Investor Relations : investors@hitgen.com; Media : media@hitgen.com; Career and Jobs : human.resources@hitgen.com

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information